『S22:E3 – Compare Your TROP2-directed ADC in Non-Small Cell Lung Cancer Treatment-Related Adverse Events Management Plan to the Experts』のカバーアート

S22:E3 – Compare Your TROP2-directed ADC in Non-Small Cell Lung Cancer Treatment-Related Adverse Events Management Plan to the Experts

S22:E3 – Compare Your TROP2-directed ADC in Non-Small Cell Lung Cancer Treatment-Related Adverse Events Management Plan to the Experts

無料で聴く

ポッドキャストの詳細を見る

このコンテンツについて

In this episode, our Faculty, Dr. Charu Aggarwal and Dr. Jacob Sands, explore the clinical impact of investigational TROP2-directed antibody-drug conjugates (ADCs), their safety profile, and expert strategies for managing potential toxicities.

Visit https://suitehome.atpointofcare.com/library/2674.03/page/0?subdomain=nsclc to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

This podcast is powered by Pinecast.

S22:E3 – Compare Your TROP2-directed ADC in Non-Small Cell Lung Cancer Treatment-Related Adverse Events Management Plan to the Expertsに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。